Baxter reports good results for cell-tissue flu vaccine

07/24/2007 | Chicago Tribune (tiered subscription model)

Baxter International said a Phase I trial showed "strong antibody responses and good tolerability" for its reformulated seasonal flu vaccine made with cell tissues. The company is intent on building its vaccine business, including a vaccine against avian flu, and the cell-based process eliminates the need for chicken eggs and speeds the production process for vaccines.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX